Roivant Sciences Ltd

2026. g. 23. sept. 20:02 UTC

Roivant Sciences Ltd shares fell sharply after Immunovant discontinued IMVT-1402 development for cutaneous lupus erythematosus due to a failed proof-of-concept study.

2026. g. 22. sept. 23:55 UTC

Roivant Sciences Ltd is higher in after-market trading following positive Phase 2 trial results for mosliciguat, showing significant improvements in pulmonary hypertension patients.

2026. g. 21. sept. 23:51 UTC

Roivant Sciences Ltd is advancing in after-market trading, currently 3.88% above its 20-day moving average and near the upper end of its one-month range.

2026. g. 18. sept. 23:10 UTC

Roivant Sciences Ltd is trading modestly higher in after-market hours, supported by broader market gains and resilient U.S. retail sales data.

2026. g. 17. sept. 23:21 UTC

Roivant Sciences Ltd is seeing notable gains in after-market trading, continuing an upward trend after finishing higher for three consecutive sessions.

2026. g. 16. sept. 23:11 UTC

Roivant Sciences Ltd shares rise in after-market trading following Stifel's initiation of coverage with a Buy rating and a price target of $51.00.

2026. g. 15. sept. 23:03 UTC

Roivant Sciences Ltd is higher in after-market trading, aligning with the broader market's upward movement. The asset remains above its 20-day moving average.

2026. g. 14. sept. 20:13 UTC

Shares of Roivant Sciences are lower in after-market hours, reflecting a notable decline since Monday's close, despite remaining above the 20-day moving average.

2026. g. 11. sept. 20:13 UTC

Roivant Sciences Ltd. shares are lower in after-market trading, amid broader market concerns over potential Federal Reserve interest rate hikes following recent inflation data.

2026. g. 10. sept. 23:31 UTC

Roivant Sciences Ltd shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

2026. g. 9. sept. 23:06 UTC

Roivant Sciences Ltd shares are higher in after-market hours, maintaining a narrow trading range since Wednesday's close and staying above the 20-day moving average.

2026. g. 8. sept. 23:06 UTC

Roivant Sciences Ltd shares are lower in after-market hours despite positive Phase 2 trial results for mosliciguat targeting pulmonary hypertension.

2026. g. 4. sept. 22:51 UTC

Roivant Sciences Ltd shares are lower in after-market trading, reflecting broader market declines and negative sentiment in the biotech sector.

2026. g. 2. sept. 20:08 UTC

Roivant Sciences Ltd shares are lower today, breaking a trend of higher closes. No specific news was identified to explain the decline.

2026. g. 1. sept. 19:36 UTC

Roivant Sciences Ltd is trading lower amid broader market sentiment and rising oil prices. The stock remains below its 20-day moving average.

2026. g. 31. aug. 22:01 UTC

Roivant Sciences Ltd shares are higher in after-hours trading, showing modest gains since Monday's close amid rising oil prices and geopolitical tensions.

2026. g. 29. aug. 00:01 UTC

Roivant Sciences Ltd shares are higher in after-market hours, reflecting notable activity despite a retracement from earlier gains. No specific news was identified.

2026. g. 28. aug. 23:01 UTC

Roivant Sciences Ltd shares are higher in after-market trading, reflecting notable activity following Friday's close, despite no specific news identified.

2026. g. 27. aug. 23:02 UTC

Roivant Sciences Ltd. shares are higher in after-market trading, remaining above the 20-day moving average despite earlier fluctuations during the session.

2026. g. 26. aug. 22:41 UTC

Roivant Sciences Ltd is trading higher in after-market hours, reflecting broader market gains. The asset has closed higher for three consecutive sessions.

2026. g. 25. aug. 23:16 UTC

Roivant Sciences Ltd. shares are lower in after-market trading, continuing a steady decline since Tuesday's close, though still above the 20-day moving average.

2026. g. 24. aug. 23:01 UTC

Roivant Sciences Ltd. shares are lower in after-market trading, retracing from an earlier session high while remaining above the 20-day moving average.

2026. g. 21. aug. 19:31 UTC

Roivant Sciences is declining in Friday's session, with no specific news identified. The stock has seen unusually high trading volume today.

2026. g. 20. aug. 23:21 UTC

Roivant Sciences Ltd. shares are lower in after-market trading amid broader market pressures, including rising bond yields and concerns over high borrowing costs.

2026. g. 19. aug. 23:26 UTC

Roivant Sciences Ltd is seeing upward momentum in after-market trading, recovering from a prior dip and nearing the upper end of its one-month trading range.

2026. g. 18. aug. 23:01 UTC

Roivant Sciences Ltd shares are lower in after-market trading, declining notably after Tuesday's close amid rising U.S. Treasury yields and inflation concerns.

2026. g. 17. aug. 19:36 UTC

Roivant Sciences shares are roughly flat amid broader market declines. The bond market faces upward pressure on yields due to inflation concerns.

2026. g. 14. aug. 19:26 UTC

Roivant Sciences Ltd. remains near unchanged amid no specific news, fluctuating around flat levels during Friday's session. It is 4.29% above its 20-day moving average.

2026. g. 13. aug. 19:36 UTC

Roivant Sciences Ltd is trading modestly higher amid broader market dynamics. Initial jobless claims rose above expectations, indicating potential softness in the labor market.

2026. g. 12. aug. 22:11 UTC

Roivant Sciences shares are higher in after-market trading, driven by a positive market reaction to the July Consumer Price Index report.